Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy
Manida Suksawat(Khon Kaen University), Watcharin Loilome(Khon Kaen University)
Cited by 18
Related Papers
PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma
|International Journal of Cancer|2010|60
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
|Oncology Reports|2016|40
Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial–Mesenchymal Transition Process
|Anticancer Research|2017|24